Get the Stockscreener App
26.99
1.30%
0.455
Inhibrx Biosciences Inc stock is traded at $26.99, with a volume of 20,105.
It is up +1.30% in the last 24 hours and up +12.61% over the past month.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
See More
Previous Close:
$26.54
Open:
$26.8
24h Volume:
20,105
Relative Volume:
0.18
Market Cap:
$390.96M
Revenue:
$1.80M
Net Income/Loss:
$1.76B
P/E Ratio:
0.2274
EPS:
118.674
Net Cash Flow:
$-149.23M
1W Performance:
-5.52%
1M Performance:
+12.61%
6M Performance:
+92.00%
1Y Performance:
+58.21%
1-Day Range:
$26.50
$27.18
1-Week Range:
$26.19
$28.86
52-Week Range:
$10.80
$30.23
Inhibrx Biosciences Inc Stock (INBX) Company Profile
Name
Inhibrx Biosciences Inc
Sector
Industry
Phone
(858) 795-4220
Address
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA
Compare INBX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INBX
Inhibrx Biosciences Inc
|
26.99 | 384.37M | 1.80M | 1.76B | -149.23M | 118.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.66 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
593.76 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.18 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
727.23 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
339.88 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Inhibrx Biosciences Inc Stock (INBX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Initiated | JMP Securities | Mkt Perform |
| Jan-23-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Mar-16-22 | Initiated | SMBC Nikko | Outperform |
| Sep-21-21 | Initiated | JMP Securities | Mkt Outperform |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Sep-14-20 | Initiated | Credit Suisse | Outperform |
| Sep-14-20 | Initiated | Evercore ISI | Outperform |
View All
Inhibrx Biosciences Inc Stock (INBX) Latest News
Leading vs lagging indicators on Inhibrx Biosciences Inc. performanceJuly 2025 Pullbacks & Weekly High Potential Stock Alerts - newser.com
Whale Trades: Will Inhibrx Biosciences Inc stock recover after earnings2025 Market Sentiment & Technical Entry and Exit Alerts - خودرو بانک
Setup Watch: Is Inhibrx Biosciences Inc. affected by consumer sentimentMarket Movement Recap & Reliable Trade Execution Plans - خودرو بانک
Acadian Asset Management LLC Boosts Stake in Inhibrx Biosciences, Inc. $INBX - MarketBeat
CEO Moves: Is Inhibrx Biosciences Inc. forming a breakout patternWeekly Trade Recap & Fast Exit/Entry Strategy Plans - خودرو بانک
Inhibrx Biosciences Inc. stock volume spike explained2025 Market Overview & Long-Term Growth Stock Strategies - newser.com
Will Inhibrx Biosciences Inc. benefit from macro trendsGap Down & Fast Moving Stock Watchlists - newser.com
Volume Recap: What are the future prospects of Inhibrx Biosciences IncQuarterly Market Summary & Daily Entry Point Trade Alerts - خودرو بانک
Is Inhibrx Biosciences Inc. stock poised for growthEarnings Summary Report & Community Driven Trade Alerts - newser.com
Trend Report: Is Inhibrx Biosciences Inc a turnaround storyJuly 2025 Technicals & Smart Allocation Stock Reports - خودرو بانک
Earnings Report: Can Inhibrx Biosciences Inc outperform in the next rallyWeekly Trend Recap & Weekly Watchlist for Hot Stocks - خودرو بانک
Growth Recap: Is Inhibrx Biosciences Inc stock forming a triangle pattern2025 EndofYear Setup & Smart Swing Trading Techniques - خودرو بانک
Aug PostEarnings: Can Inhibrx Biosciences Inc outperform in the next rallyEarnings Miss & Community Consensus Trade Alerts - خودرو بانک
What earnings revisions data tells us about Inhibrx Biosciences Inc.2025 Volume Leaders & Community Consensus Trade Signals - newser.com
Growth Recap: Whats the beta of Inhibrx Biosciences Inc stockDollar Strength & Daily Momentum Trading Reports - خودرو بانک
Custom watchlist performance reports with Inhibrx Biosciences Inc.2025 Market WrapUp & Stock Timing and Entry Methods - newser.com
What to expect from Inhibrx Biosciences Inc. in the next 30 daysBull Run & Stock Timing and Entry Methods - newser.com
Published on: 2025-09-15 18:31:07 - newser.com
Applying Wyckoff theory to Inhibrx Biosciences Inc. stock2025 Investor Takeaways & Risk Managed Trade Strategies - newser.com
Long term hold vs stop loss in Inhibrx Biosciences Inc.Layoff News & Reliable Breakout Forecasts - newser.com
Aug Rallies: Is Inhibrx Biosciences Inc forming a bullish divergenceEntry Point & Low Drawdown Momentum Trade Ideas - خودرو بانک
Gap Down: Is Inhibrx Biosciences Inc affected by consumer sentiment2025 Earnings Surprises & Low Risk High Win Rate Picks - خودرو بانک
Bluefin Capital Management LLC Acquires New Holdings in Inhibrx Biosciences, Inc. $INBX - MarketBeat
Slotnik Capital LLC Cuts Stake in Inhibrx Biosciences, Inc. $INBX - MarketBeat
Woodline Partners LP Buys New Shares in Inhibrx Biosciences, Inc. $INBX - MarketBeat
Using AI based signals to follow Inhibrx Biosciences Inc.2025 Dividend Review & Accurate Buy Signal Alerts - newser.com
Chart overlay techniques for tracking Inhibrx Biosciences Inc.2025 Institutional Moves & Weekly Watchlist for Hot Stocks - newser.com
Can a trend reversal in Inhibrx Biosciences Inc. lead to recoveryWeekly Profit Analysis & Low Risk Entry Point Guides - newser.com
Published on: 2025-09-14 01:47:46 - newser.com
Inhibrx Biosciences Inc Stock (INBX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Inhibrx Biosciences Inc Stock (INBX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Kayyem Jon Faiz | Director |
Nov 20 '24 |
Buy |
14.19 |
37,500 |
532,204 |
69,843 |
0.21%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):